BSGI helps measure tumor response to neoadjuvant chemotherapy

05/3/2010 | PR Newswire

A study involving breast cancer patients showed that breast-specific gamma imaging can accurately measure tumors after neoadjuvant chemotherapy is administered before surgery. "This allows for more precise surgical planning prior to definitive surgical procedure in this population of women," the lead researcher said.

View Full Article in:

PR Newswire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC